Delivery Order SPE2DB20D3103-SPE2DB25FQ0E8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Feraheme 510 mg/17 mL vials valued at $2,749.40. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents performance to be fulfilled at the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,382.64 to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials. This competitively awarded, firm fixed-price contract has a completion date of November 21, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,374.70 for Feraheme 510 mg/17 mL vials on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside award utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The product will be delivered to AmerisourceBergen's facility...
- The Defense Logistics Agency awarded a delivery order valued at $2,894.98 to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials on December 10, 2025, with completion scheduled for December 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $9,022.92 to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials on December 15, 2025. This firm fixed price, non-competitive delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency has awarded a $7,783.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Feraheme 510 mg/17 ml vials, with an ultimate completion date of December 9, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime vendor vehicle enables...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Feraheme 510 mg/17 mL vials. This firm fixed-price contract, valued at $17,427.93, is a non-set-aside award representing a competitively awarded delivery order with an ultimate completion date of September 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 15, 2025, for Feraheme 510 mg/17 mL vials valued at $29,112.47. This is a firm fixed-price delivery order with an ultimate completion date of December 16, 2025, and no set-aside designation was applied. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Feraheme 510 mg/17 mL vials. This contract, valued at $1,777.74 with a firm fixed price structure, represents a non-set-aside competitive award with an ultimate completion date of May 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Feraheme 510 mg/17 mL vials. This $6,002.50 firm fixed-price delivery order is set to be completed by December 17, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-competitive set-aside award and is issued as a child contract under AmerisourceBergen's larger indefinite delivery contract...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ0E8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Feraheme (ferumoxytol) 510 mg/17 mL vials valued at $18,525.38 under a firm fixed-price arrangement. The award, made on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a competitive, non-set-aside procurement for pharmaceutical supply to support federal medical needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's Medical Supply Chain, distributing a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The IDC enables the company to supply pharmaceutical products and medical commodities to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to meet federal procurement requirements and its established position within DLA's pharmaceutical procurement strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 8/26/25 |